Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FKPCV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,421
Award facts
- Contract value 100% obligated
- $28,420.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen (2 mL) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of approximately $28.4K and represents a continuation of the company's pharmaceutical supply relationship with DLA. The contract was placed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania.
This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic medications, specialty pharmaceuticals, and medical supplies to military healthcare systems worldwide. Dupixent (dupilumab) is a biologic immunosuppressant used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, making this order consistent with AmerisourceBergen's extensive portfolio of specialty medications supplied through the DLA Medical Supply Chain to support Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FKPCV?
SPE2DB25FKPCV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FKPCV worth?
The government has obligated $28,421 on SPE2DB25FKPCV.
Is contract SPE2DB25FKPCV an order under another contract?
Yes. SPE2DB25FKPCV is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKPCV competed?
The extent of competition for SPE2DB25FKPCV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award